SCHEMBL7721952

SCHEMBL7721952

CC(C)(C)OC(=O)NCC(=O)NC1C[C@@H](C(=O)O)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
AGTR2 P50052 2/20 0.38
MMP2 P08253 2/20 0.37
MMP9 P14780 1/20 0.37
EPHX1 P07099 1/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
TLR2 O60603 1/20 0.35
TLR1 Q15399 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
ANPEP P15144 1/20 0.35
GAA P10253 1/20 0.35
HSD17B10 Q99714 1/20 0.34
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7726107 1.00 BTK (0.40) BTKSMN1; SMN2AGTR2MMP2MMP9
SCHEMBL7726834 1.00 BTK (0.40) BTKSMN1; SMN2AGTR2MMP2MMP9
SCHEMBL7728179 1.00 BTK (0.40) BTKSMN1; SMN2AGTR2MMP2MMP9
SCHEMBL7726096 1.00 BTK (0.40) BTKSMN1; SMN2AGTR2MMP2MMP9
SCHEMBL7727967 1.00 BTK (0.40) BTKSMN1; SMN2AGTR2MMP2MMP9
SCHEMBL7721954 1.00 BTK (0.40) BTKSMN1; SMN2AGTR2MMP2MMP9
SCHEMBL7726401 0.89 MMP2 (0.39) BTKSMN1; SMN2MMP2MMP9EPHX1
SCHEMBL7733815 0.89 MMP2 (0.39) BTKSMN1; SMN2MMP2MMP9EPHX1
SCHEMBL7733819 0.89 MMP2 (0.39) BTKSMN1; SMN2MMP2MMP9EPHX1
SCHEMBL7726398 0.89 MMP2 (0.39) BTKSMN1; SMN2MMP2MMP9EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed